1. Market Research
  2. > Therapy Industry

Insulin Industry, March 2017 Market Reports from Top Publishers

You might be interested in: Diagnostics, Diabetes Monitoring, Diabetes, Biosimilar, Insulin Delivery, Therapy, Injectable Delivery, Pump, Prosthesis, Anti-Infective, Antidiabetics, Cancer, Biopharmaceutical, Medical Device, Diabetes Care, Pharmaceutical, Transdermal Delivery, Type 2 Diabetes, Interventional Cardiology Device, Protein.


 
1-10 of about 300 reports for Insulin

Purchase Reports From Reputable Market Research Publishers

Diabetes Drugs Industry Forecasts - China Focus

Diabetes Drugs Industry Forecasts - China Focus

  • $ 1800
  • Industry report
  • March 2017
  • by Asia Market Information & Development Company

This study focuses on China’s Diabetes Drugs industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and ...

2017 Insulin Test Volume and Sales Forecasts: US, Europe, Japan--Hospitals, Commercial Labs, POC Locations

2017 Insulin Test Volume and Sales Forecasts: US, Europe, Japan--Hospitals, Commercial Labs, POC Locations

  • $ 750
  • Industry report
  • March 2017
  • by Venture Planning Group

This new report from VPGMarketResearch provides analysis of Insulin testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country ...

Diabetes Drugs Markets in China

Diabetes Drugs Markets in China

  • $ 4000
  • Industry report
  • March 2017
  • by Asia Market Information & Development Company

China’s demand for Diabetes Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth ...

Diabetes Drugs Companies in China

Diabetes Drugs Companies in China

  • $ 1800
  • Industry report
  • March 2017
  • by Asia Market Information & Development Company

This study focuses on China’s Diabetes Drugs industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing ...

Insulin Resistance - Pipeline Review, H1 2017

Insulin Resistance - Pipeline Review, H1 2017

  • $ 2000
  • Company report
  • March 2017
  • by Global Markets Direct

Insulin Resistance - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Insulin Resistance - Pipeline Review, H1 2017, provides an overview ...

Insuline Medical Ltd

Insuline Medical Ltd

  • $ 87
  • Company report
  • March 2017
  • by Wright Investors' Service

A textual analysis of the financial results for Insuline Medical Ltd compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses ...

Biosimilar (Insulin) - Competitive Landscape and Market & Pipeline Analysis, 2017

Biosimilar (Insulin) - Competitive Landscape and Market & Pipeline Analysis, 2017

  • $ 1450
  • Industry report
  • March 2017
  • by Delve Insight

DelveInsight’s, “Biosimilar (Insulin) - Competitive Landscape and Market & Pipeline Analysis, 2017” discusses the global insulin biosimilar industry. Report analyzes that Insulin and Insulin Biosimilars ...

US Antidiabetics Drug Market Outlook 2022

US Antidiabetics Drug Market Outlook 2022

  • $ 1800
  • Industry report
  • March 2017
  • by Kuick Research

“US Antidiabetics Drug Market Outlook 2022” report gives clinical and non-clinical insight on trends associated with the development of Antidiabetics drug market in US. Report helps to identify the ...

Hypoglycemia - Pipeline Review, H1 2017

Hypoglycemia - Pipeline Review, H1 2017

  • $ 2000
  • Company report
  • February 2017
  • by Global Markets Direct

Hypoglycemia - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hypoglycemia – Pipeline Review, H1 2017, provides an overview of the ...

Global Biosimilar Insulin Market Opportunity & Clinical Insight Outlook 2022

Global Biosimilar Insulin Market Opportunity & Clinical Insight Outlook 2022

  • $ 1500
  • Industry report
  • February 2017
  • by Kuick Research

“Global Biosimilar Insulin Market Opportunity & Clinical Insight Outlook 2022” report gives comprehensive insight on clinical and non-clinical issues involved with growth of global biosimilar insulin ...

About 10000 reports for Insulin

Download Unlimited Documents from Trusted Public Sources

Insulin Market and Type 2 Diabetes Statistics in the US

  • January 2015
    140 pages
  • Insulin  

    Antidiabetics  

    Therapy  

  • United States  

View report >

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.